210 related articles for article (PubMed ID: 37335420)
21. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor expression is modulated in human and mouse prostate epithelial cells during cancer progression.
Gadkar S; Thakur M; Desouza J; Bhowmick S; Patel V; Chaudhari U; Acharya KK; Sachdeva G
Steroids; 2022 Aug; 184():109036. PubMed ID: 35413338
[TBL] [Abstract][Full Text] [Related]
23. Lobe-specific proteome changes in the dorsal-lateral and ventral prostate of TRAMP mice versus wild-type mice.
Zhang J; Wang L; Zhang Y; Li L; Higgins L; Lü J
Proteomics; 2011 Jun; 11(12):2542-9. PubMed ID: 21598396
[TBL] [Abstract][Full Text] [Related]
24. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice.
Shukla S; MacLennan GT; Flask CA; Fu P; Mishra A; Resnick MI; Gupta S
Cancer Res; 2007 Jul; 67(14):6925-35. PubMed ID: 17638904
[TBL] [Abstract][Full Text] [Related]
25. The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissue.
Wang X; Colby JK; Yang P; Fischer SM; Newman RA; Klein RD
Carcinogenesis; 2008 Jan; 29(1):120-8. PubMed ID: 17942462
[TBL] [Abstract][Full Text] [Related]
26. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
Wang L; Zhang J; Zhang Y; Nkhata K; Quealy E; Liao JD; Cleary MP; Lü J
Prostate; 2011 Sep; 71(13):1429-40. PubMed ID: 21360561
[TBL] [Abstract][Full Text] [Related]
27. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice.
Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH
Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105
[TBL] [Abstract][Full Text] [Related]
28. Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
Abedinpour P; Baron VT; Welsh J; Borgström P
Prostate; 2011 Jun; 71(8):813-23. PubMed ID: 21456064
[TBL] [Abstract][Full Text] [Related]
29. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J
Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406
[TBL] [Abstract][Full Text] [Related]
30. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
Jain AK; Raina K; Agarwal R
Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
[TBL] [Abstract][Full Text] [Related]
31. Differential tempol effects in prostatic cancer: angiogenesis and short- and long-term treatments.
Santos FR; Rossetto IMU; Montico F; de Almeida Lamas C; Cagnon VHA
J Mol Histol; 2024 Jun; 55(3):253-264. PubMed ID: 38551737
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
33. Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.
Cho HJ; Lim DY; Kwon GT; Kim JH; Huang Z; Song H; Oh YS; Kang YH; Lee KW; Dong Z; Park JH
Int J Mol Sci; 2016 Feb; 17(2):264. PubMed ID: 26907265
[TBL] [Abstract][Full Text] [Related]
34. P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.
Li T; Wang F; Dang Y; Dong J; Zhang Y; Zhang C; Liu P; Gao Y; Wang X; Yang S; Lu S
Int J Biol Sci; 2019; 15(10):2198-2210. PubMed ID: 31592235
[TBL] [Abstract][Full Text] [Related]
35. Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Kim SJ; Amankwah E; Connors S; Park HY; Rincon M; Cornnell H; Chornokur G; Hashim AI; Choi J; Tsai YY; Engelman RW; Kumar N; Park JY
Cancer Prev Res (Phila); 2014 Apr; 7(4):435-44. PubMed ID: 24501325
[TBL] [Abstract][Full Text] [Related]
36. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Said N; Frierson HF; Chernauskas D; Conaway M; Motamed K; Theodorescu D
Oncogene; 2009 Oct; 28(39):3487-98. PubMed ID: 19597474
[TBL] [Abstract][Full Text] [Related]
37. SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis.
Huss WJ; Barrios RJ; Greenberg NM
Mol Cancer Ther; 2003 Jul; 2(7):611-6. PubMed ID: 12883033
[TBL] [Abstract][Full Text] [Related]
38. Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
Teichert F; Verschoyle RD; Greaves P; Edwards RE; Teahan O; Jones DJ; Wilson ID; Farmer PB; Steward WP; Gant TW; Gescher AJ; Keun HC
Prostate; 2008 Jul; 68(10):1035-47. PubMed ID: 18459103
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Zhang J; Wang L; Anderson LB; Witthuhn B; Xu Y; Lü J
Cancer Prev Res (Phila); 2010 Aug; 3(8):994-1006. PubMed ID: 20647336
[TBL] [Abstract][Full Text] [Related]
40. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
